Related Experiment Video
Updated: Jun 12, 2026
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W
Marko Roblek1, Stefan Schüchner, Veronika Huber
1Department of Medical Biochemistry, Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria.
Background:
Disease-linked missense mutations can alter a protein's function with fatal consequences for the affected individual. How a single amino acid substitution in a protein affects its properties, is difficult to study in the context of the cellular proteome, because mutant proteins can often not be traced in cells due to the lack of mutation-specific detection tools. Antibodies, however, with their exquisite epitope specificity permit the detection of single amino acid substitutions but are not available for the vast majority of disease-causing mutant proteins. One of the most frequently missense-mutated human genes is the LMNA gene coding for A-type lamins. Mutations in LMNA cause phenotypically heterogenous, mostly autosomal-dominant inherited diseases, termed laminopathies. The molecular mechanisms underlying the phenotypic heterogeneity of laminopathies, however, are not well understood. Hence, the goal of this study was the development of monoclonal antibodies specific for disease-linked point-mutant A-type lamins.
Methodology/Principal Findings:
Using two different approaches of antigen presentation, namely KLH-coupled peptides and the display of a complete protein domain fused to the Hepatitis B virus capsid protein, we developed monoclonal antibodies against two disease-associated lamin A/C mutants. Both antibodies display exquisite specificity for the respective mutant proteins. We show that with the help of these novel antibodies it is now possible for the first time to study specifically the properties of the mutant proteins in primary patient cells in the background of wild-type protein.
Conclusions:
We report here the development of two point-mutant specific antibodies against A-type lamins. While synthetic peptides may be the prime choice of antigen, our results show that a given target sequence may have to be presented in alternative ways to ensure the induction of a mutant-specific immune response. Point-mutant specific antibodies will represent valuable tools for basic and clinical research on a number of hereditary as well as acquired diseases caused by dominant missense mutations.
Insights
Researchers developed novel monoclonal antibodies targeting specific disease-linked mutations in A-type lamins. These antibodies enable the study of mutant proteins in patient cells, advancing research into laminopathies and related diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Missense mutations in genes like LMNA can alter protein function, leading to severe diseases called laminopathies.
- Studying mutant proteins in cells is challenging due to a lack of specific detection tools.
- A-type lamins are frequently missense-mutated, causing diverse inherited disorders with poorly understood mechanisms.
Purpose of the Study:
- To develop highly specific monoclonal antibodies for detecting disease-linked point-mutant A-type lamins.
- To create tools for investigating the cellular behavior and impact of specific lamin mutations.
Main Methods:
- Employed two antigen presentation strategies: KLH-coupled peptides and a complete protein domain fused to the Hepatitis B virus capsid protein.
- Generated and screened monoclonal antibodies for specificity against disease-associated lamin A/C mutants.
Main Results:
- Successfully developed two monoclonal antibodies with exquisite specificity for their respective mutant A-type lamin targets.
- Demonstrated the capability to specifically detect and study mutant lamin proteins within primary patient cells, distinguishing them from wild-type proteins.
Conclusions:
- The study reports the successful development of point-mutant specific antibodies against A-type lamins.
- Alternative antigen presentation methods are crucial for inducing specific immune responses against target mutations.
- These novel antibodies are valuable tools for basic and clinical research on diseases caused by dominant missense mutations.
More Related Videos
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
09:45Production of Monoclonal Antibodies Targeting Aminopeptidase N in the Porcine Intestinal Mucosal Epithelium
Published on: May 18, 2021